AtriCure (ATRC) SEC Filings: History & Chart

AtriCure, Inc.(ATRC)

Medical - Instruments & Supplies · Mason, OH

$56.42+0.05 (+0.09%)

Delayed quote: Oct 6, 2026, 9:40 AM EDT

About AtriCure, Inc.

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform tissue ablation with a single device. The Coolrail device facilitates the creation of longer linear ablation lines. For varying lengths of linear ablations, the CryoICE Cryoablation System is available. Furthermore, the EPi-Sense Guided Coagulation System is a single-use solution for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. AtriCure also provides systems for cardiac appendage management and soft-tissue closure. The AtriClip System is an implantable device accompanied by a disposable applier, while the LARIAT System offers a suture-based solution for soft-tissue closure, compatible with various anatomical shapes. Additionally, AtriCure offers supplementary surgical tools including Lumitip Dissectors, designed to separate tissues for optimal access, Glidepath guides for precise clamp placement, and Subtle Cannulas facilitating access for EPi-Sense catheters. A suite of reusable cardiac surgery instruments, crucial for procedures involving heart valve repair or replacement, is also available. The company distributes its offerings through a combination of independent distributors and direct sales personnel. Founded in 2000, AtriCure maintains its headquarters in Mason, Ohio.

Mason, OH

1,350 employees

www.atricure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Michael H. Carrel

View full financials

Form	Filing Date	Accepted	Document
SC 13G/A	Oct 5, 2026	Oct 5, 2026	View filing
4	Sep 24, 2026	Sep 24, 2026	View filing
4	Sep 14, 2026	Sep 14, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
4	Aug 26, 2026	Aug 26, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
4	Aug 7, 2026	Aug 7, 2026	View filing
4	Aug 7, 2026	Aug 7, 2026	View filing
4	Aug 3, 2026	Aug 3, 2026	View filing
4	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 30, 2026	Jul 30, 2026	View filing
S-8	Jul 27, 2026	Jul 27, 2026	View filing
S-8	Jul 27, 2026	Jul 27, 2026	View filing
10-Q	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jul 23, 2026	Jul 23, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
SD	May 27, 2026	May 27, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing
4	May 20, 2026	May 20, 2026	View filing

SEC Filings

Recent Filings